Parkinson Disease

The FDA has approved the first and only treatment option for levodopa-induced dyskinesia in patients with Parkinson disease.

In a large longitudinal analysis, researchers developed and tested an algorithm to better predict cognitive impairment before the onset of Parkinson disease. To find out how their algorithm performed, read...

In a recent study, researchers sought to investigate the effects of exenatide on motor skills in a cohort of patients with Parkinson disease.

A recent study evaluated melanoma patients’ risk of developing Parkinson disease, compared with controls. To see results of the study, including which patients had the highest risk, read more.

Statins lower cholesterol, but higher cholesterol has been shown to lower the risk of Parkinson disease. A recent analysis aimed to evaluate this relationship further. To see the results, including which...

A study in JAMA Neurology assessed whether light therapy is an effective, safe treatment for excessive sleepiness in Parkinson disease.

The FDA has approved Xadago, an add-on treatment for patients with Parkinson disease who experience “off” episodes.

Researchers designed a study to decide which clinical measures of physical function best represent long-term electromyography in individuals with Parkinson disease.

Investigators involved in the ongoing Parkinson’s Progression Markers Initiative study are aiming to define biomarkers of Parkinson disease diagnosis and progression. Here is what their latest analysis...

Investigators involved in the ongoing Parkinson’s Progression Markers Initiative study are aiming to define biomarkers of Parkinson disease diagnosis and progression. Here is what their latest analysis...